5 Small-cap Biotech ETFs to Watch in 2026

2026-05-27 16:15:00 ET

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to b iotech ETFs, they give sector participants exposure to many biotech companies via one vehicle.

ETFs are a popular choice as they allow investors to enter the market more safely compared to investing in standalone stocks. A key advantage is that even if one company in the ETF takes a hit, the impact will be less direct.

Below the Investing News Network takes a look at five small-cap biotech ETFs. The funds were selected using ETFdb.com , and only ETFs with total assets under management (AUM) under US$100 million as of May 26, 2026, were considered.

For further details see: